Table of Content

1 Anti-Nuclear Radiation Drug Market Overview
1.1 Anti-Nuclear Radiation Drug Product Overview
1.2 Anti-Nuclear Radiation Drug Market Segment by Type
1.2.1 Potassium Iodide (KI)
1.2.2 Prussian Blue
1.2.3 Diethylenetriamine Pentaacetate (DTPA)
1.2.4 Filgrastim
1.2.5 Amifostine
1.2.6 Ex-Rad
1.3 Global Anti-Nuclear Radiation Drug Market Size by Type
1.3.1 Global Anti-Nuclear Radiation Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-Nuclear Radiation Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Nuclear Radiation Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Nuclear Radiation Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Nuclear Radiation Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Nuclear Radiation Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Nuclear Radiation Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Nuclear Radiation Drug Sales Breakdown by Type (2018-2024)
2 Global Anti-Nuclear Radiation Drug Market Competition by Company
2.1 Global Top Players by Anti-Nuclear Radiation Drug Sales (2018-2024)
2.2 Global Top Players by Anti-Nuclear Radiation Drug Revenue (2018-2024)
2.3 Global Top Players by Anti-Nuclear Radiation Drug Price (2018-2024)
2.4 Global Top Manufacturers Anti-Nuclear Radiation Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Nuclear Radiation Drug Market Competitive Situation and Trends
2.5.1 Anti-Nuclear Radiation Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Nuclear Radiation Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Nuclear Radiation Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Nuclear Radiation Drug Market
2.8 Key Manufacturers Anti-Nuclear Radiation Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Nuclear Radiation Drug Status and Outlook by Region
3.1 Global Anti-Nuclear Radiation Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-Nuclear Radiation Drug Historic Market Size by Region
3.2.1 Global Anti-Nuclear Radiation Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Nuclear Radiation Drug Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Nuclear Radiation Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Nuclear Radiation Drug Forecasted Market Size by Region
3.3.1 Global Anti-Nuclear Radiation Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-Nuclear Radiation Drug Sales in Value by Region (2024-2029)
3.3.3 Global Anti-Nuclear Radiation Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-Nuclear Radiation Drug by Sales Channel
4.1 Anti-Nuclear Radiation Drug Market Segment by Sales Channel
4.1.1 Online Sales
4.1.2 Offline Sales
4.2 Global Anti-Nuclear Radiation Drug Market Size by Sales Channel
4.2.1 Global Anti-Nuclear Radiation Drug Market Size Overview by Sales Channel (2018-2029)
4.2.2 Global Anti-Nuclear Radiation Drug Historic Market Size Review by Sales Channel (2018-2024)
4.2.3 Global Anti-Nuclear Radiation Drug Forecasted Market Size by Sales Channel (2024-2029)
4.3 Key Regions Market Size Segment by Sales Channel
4.3.1 North America Anti-Nuclear Radiation Drug Sales Breakdown by Sales Channel (2018-2024)
4.3.2 Europe Anti-Nuclear Radiation Drug Sales Breakdown by Sales Channel (2018-2024)
4.3.3 Asia-Pacific Anti-Nuclear Radiation Drug Sales Breakdown by Sales Channel (2018-2024)
4.3.4 Latin America Anti-Nuclear Radiation Drug Sales Breakdown by Sales Channel (2018-2024)
4.3.5 Middle East and Africa Anti-Nuclear Radiation Drug Sales Breakdown by Sales Channel (2018-2024)
5 North America Anti-Nuclear Radiation Drug by Country
5.1 North America Anti-Nuclear Radiation Drug Historic Market Size by Country
5.1.1 North America Anti-Nuclear Radiation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-Nuclear Radiation Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Nuclear Radiation Drug Sales in Value by Country (2018-2024)
5.2 North America Anti-Nuclear Radiation Drug Forecasted Market Size by Country
5.2.1 North America Anti-Nuclear Radiation Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-Nuclear Radiation Drug Sales in Value by Country (2024-2029)
6 Europe Anti-Nuclear Radiation Drug by Country
6.1 Europe Anti-Nuclear Radiation Drug Historic Market Size by Country
6.1.1 Europe Anti-Nuclear Radiation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-Nuclear Radiation Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Nuclear Radiation Drug Sales in Value by Country (2018-2024)
6.2 Europe Anti-Nuclear Radiation Drug Forecasted Market Size by Country
6.2.1 Europe Anti-Nuclear Radiation Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-Nuclear Radiation Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-Nuclear Radiation Drug by Region
7.1 Asia-Pacific Anti-Nuclear Radiation Drug Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Nuclear Radiation Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-Nuclear Radiation Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Nuclear Radiation Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Nuclear Radiation Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Nuclear Radiation Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-Nuclear Radiation Drug Sales in Value by Region (2024-2029)
8 Latin America Anti-Nuclear Radiation Drug by Country
8.1 Latin America Anti-Nuclear Radiation Drug Historic Market Size by Country
8.1.1 Latin America Anti-Nuclear Radiation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-Nuclear Radiation Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Nuclear Radiation Drug Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Nuclear Radiation Drug Forecasted Market Size by Country
8.2.1 Latin America Anti-Nuclear Radiation Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-Nuclear Radiation Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-Nuclear Radiation Drug by Country
9.1 Middle East and Africa Anti-Nuclear Radiation Drug Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Nuclear Radiation Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-Nuclear Radiation Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Nuclear Radiation Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Nuclear Radiation Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Nuclear Radiation Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-Nuclear Radiation Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen Anti-Nuclear Radiation Drug Products Offered
10.1.5 Amgen Recent Development
10.2 Humanwell Healthcare
10.2.1 Humanwell Healthcare Company Information
10.2.2 Humanwell Healthcare Introduction and Business Overview
10.2.3 Humanwell Healthcare Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Humanwell Healthcare Anti-Nuclear Radiation Drug Products Offered
10.2.5 Humanwell Healthcare Recent Development
10.3 Jiangsu Wuzhong Pharmaceutical Group
10.3.1 Jiangsu Wuzhong Pharmaceutical Group Company Information
10.3.2 Jiangsu Wuzhong Pharmaceutical Group Introduction and Business Overview
10.3.3 Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Products Offered
10.3.5 Jiangsu Wuzhong Pharmaceutical Group Recent Development
10.4 Hisun Pharmaceutical
10.4.1 Hisun Pharmaceutical Company Information
10.4.2 Hisun Pharmaceutical Introduction and Business Overview
10.4.3 Hisun Pharmaceutical Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hisun Pharmaceutical Anti-Nuclear Radiation Drug Products Offered
10.4.5 Hisun Pharmaceutical Recent Development
10.5 Beijing Centergate Technologies
10.5.1 Beijing Centergate Technologies Company Information
10.5.2 Beijing Centergate Technologies Introduction and Business Overview
10.5.3 Beijing Centergate Technologies Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Beijing Centergate Technologies Anti-Nuclear Radiation Drug Products Offered
10.5.5 Beijing Centergate Technologies Recent Development
10.6 Lisheng Pharmaceutical
10.6.1 Lisheng Pharmaceutical Company Information
10.6.2 Lisheng Pharmaceutical Introduction and Business Overview
10.6.3 Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Products Offered
10.6.5 Lisheng Pharmaceutical Recent Development
10.7 Bayer AG
10.7.1 Bayer AG Company Information
10.7.2 Bayer AG Introduction and Business Overview
10.7.3 Bayer AG Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bayer AG Anti-Nuclear Radiation Drug Products Offered
10.7.5 Bayer AG Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 GlaxoSmithKline Anti-Nuclear Radiation Drug Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 Pfizer
10.9.1 Pfizer Company Information
10.9.2 Pfizer Introduction and Business Overview
10.9.3 Pfizer Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Pfizer Anti-Nuclear Radiation Drug Products Offered
10.9.5 Pfizer Recent Development
10.10 Onconova
10.10.1 Onconova Company Information
10.10.2 Onconova Introduction and Business Overview
10.10.3 Onconova Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Onconova Anti-Nuclear Radiation Drug Products Offered
10.10.5 Onconova Recent Development
10.11 Novartis AG
10.11.1 Novartis AG Company Information
10.11.2 Novartis AG Introduction and Business Overview
10.11.3 Novartis AG Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Novartis AG Anti-Nuclear Radiation Drug Products Offered
10.11.5 Novartis AG Recent Development
10.12 Teva Pharmaceuticals
10.12.1 Teva Pharmaceuticals Company Information
10.12.2 Teva Pharmaceuticals Introduction and Business Overview
10.12.3 Teva Pharmaceuticals Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Teva Pharmaceuticals Anti-Nuclear Radiation Drug Products Offered
10.12.5 Teva Pharmaceuticals Recent Development
10.13 Clinigen
10.13.1 Clinigen Company Information
10.13.2 Clinigen Introduction and Business Overview
10.13.3 Clinigen Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Clinigen Anti-Nuclear Radiation Drug Products Offered
10.13.5 Clinigen Recent Development
10.14 Sun Pharmaceutical
10.14.1 Sun Pharmaceutical Company Information
10.14.2 Sun Pharmaceutical Introduction and Business Overview
10.14.3 Sun Pharmaceutical Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Sun Pharmaceutical Anti-Nuclear Radiation Drug Products Offered
10.14.5 Sun Pharmaceutical Recent Development
10.15 Taj Pharmaceuticals
10.15.1 Taj Pharmaceuticals Company Information
10.15.2 Taj Pharmaceuticals Introduction and Business Overview
10.15.3 Taj Pharmaceuticals Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Taj Pharmaceuticals Anti-Nuclear Radiation Drug Products Offered
10.15.5 Taj Pharmaceuticals Recent Development
10.16 Merro Pharmaceutical
10.16.1 Merro Pharmaceutical Company Information
10.16.2 Merro Pharmaceutical Introduction and Business Overview
10.16.3 Merro Pharmaceutical Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Merro Pharmaceutical Anti-Nuclear Radiation Drug Products Offered
10.16.5 Merro Pharmaceutical Recent Development
10.17 Luye Pharma
10.17.1 Luye Pharma Company Information
10.17.2 Luye Pharma Introduction and Business Overview
10.17.3 Luye Pharma Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Luye Pharma Anti-Nuclear Radiation Drug Products Offered
10.17.5 Luye Pharma Recent Development
10.18 Mingren Pharma
10.18.1 Mingren Pharma Company Information
10.18.2 Mingren Pharma Introduction and Business Overview
10.18.3 Mingren Pharma Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Mingren Pharma Anti-Nuclear Radiation Drug Products Offered
10.18.5 Mingren Pharma Recent Development
10.19 Gilead Sciences
10.19.1 Gilead Sciences Company Information
10.19.2 Gilead Sciences Introduction and Business Overview
10.19.3 Gilead Sciences Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Gilead Sciences Anti-Nuclear Radiation Drug Products Offered
10.19.5 Gilead Sciences Recent Development
10.20 Johnson & Johnson
10.20.1 Johnson & Johnson Company Information
10.20.2 Johnson & Johnson Introduction and Business Overview
10.20.3 Johnson & Johnson Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Johnson & Johnson Anti-Nuclear Radiation Drug Products Offered
10.20.5 Johnson & Johnson Recent Development
10.21 Merck KGaA
10.21.1 Merck KGaA Company Information
10.21.2 Merck KGaA Introduction and Business Overview
10.21.3 Merck KGaA Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Merck KGaA Anti-Nuclear Radiation Drug Products Offered
10.21.5 Merck KGaA Recent Development
10.22 Genentech Inc.
10.22.1 Genentech Inc. Company Information
10.22.2 Genentech Inc. Introduction and Business Overview
10.22.3 Genentech Inc. Anti-Nuclear Radiation Drug Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Genentech Inc. Anti-Nuclear Radiation Drug Products Offered
10.22.5 Genentech Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Nuclear Radiation Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Nuclear Radiation Drug Industrial Chain Analysis
11.4 Anti-Nuclear Radiation Drug Market Dynamics
11.4.1 Anti-Nuclear Radiation Drug Industry Trends
11.4.2 Anti-Nuclear Radiation Drug Market Drivers
11.4.3 Anti-Nuclear Radiation Drug Market Challenges
11.4.4 Anti-Nuclear Radiation Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Nuclear Radiation Drug Distributors
12.3 Anti-Nuclear Radiation Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Potassium Iodide (KI)
Table 2. Major Company of Prussian Blue
Table 3. Major Company of Diethylenetriamine Pentaacetate (DTPA)
Table 4. Major Company of Filgrastim
Table 5. Major Company of Amifostine
Table 6. Major Company of Ex-Rad
Table 7. Global Anti-Nuclear Radiation Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (K Units)
Table 9. Global Anti-Nuclear Radiation Drug Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (US& Million)
Table 11. Global Anti-Nuclear Radiation Drug Market Share in Value by Type (2018-2024)
Table 12. Global Anti-Nuclear Radiation Drug Price by Type (2018-2024) & (US$/Unit)
Table 13. Global Anti-Nuclear Radiation Drug Sales by Type (2024-2029) & (K Units)
Table 14. Global Anti-Nuclear Radiation Drug Sales Market Share in Volume by Type (2024-2029)
Table 15. Global Anti-Nuclear Radiation Drug Sales by Type (2024-2029) & (US$ Million)
Table 16. Global Anti-Nuclear Radiation Drug Sales Market Share in Value by Type (2024-2029)
Table 17. Global Anti-Nuclear Radiation Drug Price by Type (2024-2029) & (US$/Unit)
Table 18. North America Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (K Units)
Table 19. North America Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Anti-Nuclear Radiation Drug Sales (K Units) by Type (2018-2024)
Table 21. Europe Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Anti-Nuclear Radiation Drug Sales (K Units) by Type (2018-2024)
Table 23. Asia-Pacific Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Anti-Nuclear Radiation Drug Sales (K Units) by Type (2018-2024)
Table 25. Latin America Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Anti-Nuclear Radiation Drug Sales (K Units) by Type (2018-2024)
Table 27. Middle East and Africa Anti-Nuclear Radiation Drug Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Anti-Nuclear Radiation Drug Sales by Company (2018-2024) & (K Units)
Table 29. Global Anti-Nuclear Radiation Drug Sales Share by Company (2018-2024)
Table 30. Global Anti-Nuclear Radiation Drug Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Anti-Nuclear Radiation Drug Revenue Share by Company (2018-2024)
Table 32. Global Market Anti-Nuclear Radiation Drug Price by Company (2018-2024) & (US$/Unit)
Table 33. Global Anti-Nuclear Radiation Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Anti-Nuclear Radiation Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Nuclear Radiation Drug as of 2022)
Table 36. Date of Key Manufacturers Enter into Anti-Nuclear Radiation Drug Market
Table 37. Key Manufacturers Anti-Nuclear Radiation Drug Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Anti-Nuclear Radiation Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Global Anti-Nuclear Radiation Drug Sales by Region (2018-2024) & (K Units)
Table 41. Global Anti-Nuclear Radiation Drug Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Anti-Nuclear Radiation Drug Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Anti-Nuclear Radiation Drug Sales Market Share in Value by Region (2018-2024)
Table 44. Global Anti-Nuclear Radiation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 45. Global Anti-Nuclear Radiation Drug Sales by Region (2024-2029) & (K Units)
Table 46. Global Anti-Nuclear Radiation Drug Sales Market Share in Volume by Region (2024-2029)
Table 47. Global Anti-Nuclear Radiation Drug Sales by Region (2024-2029) & (US$ Million)
Table 48. Global Anti-Nuclear Radiation Drug Sales Market Share in Value by Region (2024-2029)
Table 49. Global Anti-Nuclear Radiation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 50. Global Anti-Nuclear Radiation Drug Sales by Sales Channel: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. Global Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) & (K Units)
Table 52. Global Anti-Nuclear Radiation Drug Sales Market Share in Volume by Sales Channel (2018-2024)
Table 53. Global Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) & (US$ Million)
Table 54. Global Anti-Nuclear Radiation Drug Sales Market Share in Value by Sales Channel (2018-2024)
Table 55. Global Anti-Nuclear Radiation Drug Price by Sales Channel (2018-2024) & (US$/Unit)
Table 56. Global Anti-Nuclear Radiation Drug Sales by Sales Channel (2024-2029) & (K Units)
Table 57. Global Anti-Nuclear Radiation Drug Sales Market Share in Volume by Sales Channel (2024-2029)
Table 58. Global Anti-Nuclear Radiation Drug Sales by Sales Channel (2024-2029) & (US$ Million)
Table 59. Global Anti-Nuclear Radiation Drug Sales Market Share in Value by Sales Channel (2024-2029)
Table 60. Global Anti-Nuclear Radiation Drug Price by Sales Channel (2024-2029) & (US$/Unit)
Table 61. North America Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) (K Units)
Table 62. North America Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) & (US$ Million)
Table 63. Europe Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) (K Units)
Table 64. Europe Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) (K Units)
Table 66. Asia-Pacific Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) & (US$ Million)
Table 67. Latin America Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) (K Units)
Table 68. Latin America Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) (K Units)
Table 70. Middle East and Africa Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2024) & (US$ Million)
Table 71. North America Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (K Units)
Table 72. North America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2018-2024)
Table 75. North America Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (K Units)
Table 76. North America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2024-2029)
Table 77. North America Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (US$ Million)
Table 78. North America Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2024-2029)
Table 79. Europe Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (K Units)
Table 80. Europe Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (K Units)
Table 84. Europe Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2024-2029)
Table 85. Europe Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (US$ Million)
Table 86. Europe Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2024-2029)
Table 87. Asia-Pacific Anti-Nuclear Radiation Drug Sales by Region (2018-2024) & (K Units)
Table 88. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Anti-Nuclear Radiation Drug Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Anti-Nuclear Radiation Drug Sales by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Volume by Region (2024-2029)
Table 93. Asia-Pacific Anti-Nuclear Radiation Drug Sales by Region (2024-2029) & (US$ Million)
Table 94. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Value by Region (2024-2029)
Table 95. Latin America Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (K Units)
Table 96. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (K Units)
Table 100. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2024-2029)
Table 101. Latin America Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (US$ Million)
Table 102. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2024-2029)
Table 103. Middle East and Africa Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (K Units)
Table 104. Middle East and Africa Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Anti-Nuclear Radiation Drug Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (K Units)
Table 108. Middle East and Africa Anti-Nuclear Radiation Drug Sales Market Share in Volume by Country (2024-2029)
Table 109. Middle East and Africa Anti-Nuclear Radiation Drug Sales by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Anti-Nuclear Radiation Drug Sales Market Share in Value by Country (2024-2029)
Table 111. Amgen Company Information
Table 112. Amgen Introduction and Business Overview
Table 113. Amgen Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 114. Amgen Anti-Nuclear Radiation Drug Product
Table 115. Amgen Recent Development
Table 116. Humanwell Healthcare Company Information
Table 117. Humanwell Healthcare Introduction and Business Overview
Table 118. Humanwell Healthcare Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 119. Humanwell Healthcare Anti-Nuclear Radiation Drug Product
Table 120. Humanwell Healthcare Recent Development
Table 121. Jiangsu Wuzhong Pharmaceutical Group Company Information
Table 122. Jiangsu Wuzhong Pharmaceutical Group Introduction and Business Overview
Table 123. Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 124. Jiangsu Wuzhong Pharmaceutical Group Anti-Nuclear Radiation Drug Product
Table 125. Jiangsu Wuzhong Pharmaceutical Group Recent Development
Table 126. Hisun Pharmaceutical Company Information
Table 127. Hisun Pharmaceutical Introduction and Business Overview
Table 128. Hisun Pharmaceutical Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 129. Hisun Pharmaceutical Anti-Nuclear Radiation Drug Product
Table 130. Hisun Pharmaceutical Recent Development
Table 131. Beijing Centergate Technologies Company Information
Table 132. Beijing Centergate Technologies Introduction and Business Overview
Table 133. Beijing Centergate Technologies Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 134. Beijing Centergate Technologies Anti-Nuclear Radiation Drug Product
Table 135. Beijing Centergate Technologies Recent Development
Table 136. Lisheng Pharmaceutical Company Information
Table 137. Lisheng Pharmaceutical Introduction and Business Overview
Table 138. Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 139. Lisheng Pharmaceutical Anti-Nuclear Radiation Drug Product
Table 140. Lisheng Pharmaceutical Recent Development
Table 141. Bayer AG Company Information
Table 142. Bayer AG Introduction and Business Overview
Table 143. Bayer AG Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 144. Bayer AG Anti-Nuclear Radiation Drug Product
Table 145. Bayer AG Recent Development
Table 146. GlaxoSmithKline Company Information
Table 147. GlaxoSmithKline Introduction and Business Overview
Table 148. GlaxoSmithKline Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 149. GlaxoSmithKline Anti-Nuclear Radiation Drug Product
Table 150. GlaxoSmithKline Recent Development
Table 151. Pfizer Company Information
Table 152. Pfizer Introduction and Business Overview
Table 153. Pfizer Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 154. Pfizer Anti-Nuclear Radiation Drug Product
Table 155. Pfizer Recent Development
Table 156. Onconova Company Information
Table 157. Onconova Introduction and Business Overview
Table 158. Onconova Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 159. Onconova Anti-Nuclear Radiation Drug Product
Table 160. Onconova Recent Development
Table 161. Novartis AG Company Information
Table 162. Novartis AG Introduction and Business Overview
Table 163. Novartis AG Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 164. Novartis AG Anti-Nuclear Radiation Drug Product
Table 165. Novartis AG Recent Development
Table 166. Teva Pharmaceuticals Company Information
Table 167. Teva Pharmaceuticals Introduction and Business Overview
Table 168. Teva Pharmaceuticals Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 169. Teva Pharmaceuticals Anti-Nuclear Radiation Drug Product
Table 170. Teva Pharmaceuticals Recent Development
Table 171. Clinigen Company Information
Table 172. Clinigen Introduction and Business Overview
Table 173. Clinigen Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 174. Clinigen Anti-Nuclear Radiation Drug Product
Table 175. Clinigen Recent Development
Table 176. Sun Pharmaceutical Company Information
Table 177. Sun Pharmaceutical Introduction and Business Overview
Table 178. Sun Pharmaceutical Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 179. Sun Pharmaceutical Anti-Nuclear Radiation Drug Product
Table 180. Sun Pharmaceutical Recent Development
Table 181. Taj Pharmaceuticals Company Information
Table 182. Taj Pharmaceuticals Introduction and Business Overview
Table 183. Taj Pharmaceuticals Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 184. Taj Pharmaceuticals Anti-Nuclear Radiation Drug Product
Table 185. Taj Pharmaceuticals Recent Development
Table 186. Merro Pharmaceutical Company Information
Table 187. Merro Pharmaceutical Introduction and Business Overview
Table 188. Merro Pharmaceutical Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 189. Merro Pharmaceutical Anti-Nuclear Radiation Drug Product
Table 190. Merro Pharmaceutical Recent Development
Table 191. Luye Pharma Company Information
Table 192. Luye Pharma Introduction and Business Overview
Table 193. Luye Pharma Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 194. Luye Pharma Anti-Nuclear Radiation Drug Product
Table 195. Luye Pharma Recent Development
Table 196. Mingren Pharma Company Information
Table 197. Mingren Pharma Introduction and Business Overview
Table 198. Mingren Pharma Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 199. Mingren Pharma Anti-Nuclear Radiation Drug Product
Table 200. Mingren Pharma Recent Development
Table 201. Gilead Sciences Company Information
Table 202. Gilead Sciences Introduction and Business Overview
Table 203. Gilead Sciences Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 204. Gilead Sciences Anti-Nuclear Radiation Drug Product
Table 205. Gilead Sciences Recent Development
Table 206. Johnson & Johnson Company Information
Table 207. Johnson & Johnson Introduction and Business Overview
Table 208. Johnson & Johnson Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 209. Johnson & Johnson Anti-Nuclear Radiation Drug Product
Table 210. Johnson & Johnson Recent Development
Table 211. Merck KGaA Company Information
Table 212. Merck KGaA Introduction and Business Overview
Table 213. Merck KGaA Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 214. Merck KGaA Anti-Nuclear Radiation Drug Product
Table 215. Merck KGaA Recent Development
Table 216. Genentech Inc. Company Information
Table 217. Genentech Inc. Introduction and Business Overview
Table 218. Genentech Inc. Anti-Nuclear Radiation Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 219. Genentech Inc. Anti-Nuclear Radiation Drug Product
Table 220. Genentech Inc. Recent Development
Table 221. Key Raw Materials Lists
Table 222. Raw Materials Key Suppliers Lists
Table 223. Anti-Nuclear Radiation Drug Market Trends
Table 224. Anti-Nuclear Radiation Drug Market Drivers
Table 225. Anti-Nuclear Radiation Drug Market Challenges
Table 226. Anti-Nuclear Radiation Drug Market Restraints
Table 227. Anti-Nuclear Radiation Drug Distributors List
Table 228. Anti-Nuclear Radiation Drug Downstream Customers
Table 229. Research Programs/Design for This Report
Table 230. Key Data Information from Secondary Sources
Table 231. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Nuclear Radiation Drug Product Picture
Figure 2. Global Anti-Nuclear Radiation Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Anti-Nuclear Radiation Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Anti-Nuclear Radiation Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Potassium Iodide (KI)
Figure 6. Global Potassium Iodide (KI) Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Prussian Blue
Figure 8. Global Prussian Blue Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Diethylenetriamine Pentaacetate (DTPA)
Figure 10. Global Diethylenetriamine Pentaacetate (DTPA) Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Filgrastim
Figure 12. Global Filgrastim Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Amifostine
Figure 14. Global Amifostine Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Product Picture of Ex-Rad
Figure 16. Global Ex-Rad Sales YoY Growth (2018-2029) & (K Units)
Figure 17. Global Anti-Nuclear Radiation Drug Sales by Type (2018-2029) & (US$ Million)
Figure 18. Global Anti-Nuclear Radiation Drug Sales Market Share by Type in 2022 & 2029
Figure 19. North America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Type in 2022
Figure 20. North America Anti-Nuclear Radiation Drug Sales Market Share in Value by Type in 2022
Figure 21. Europe Anti-Nuclear Radiation Drug Sales Market Share in Volume by Type in 2022
Figure 22. Europe Anti-Nuclear Radiation Drug Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Value by Type in 2022
Figure 25. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Anti-Nuclear Radiation Drug Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Anti-Nuclear Radiation Drug Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Nuclear Radiation Drug Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Nuclear Radiation Drug Revenue in 2022
Figure 31. Anti-Nuclear Radiation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Online Sales
Figure 33. Global Online Sales Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Offline Sales
Figure 35. Global Offline Sales Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Anti-Nuclear Radiation Drug Sales by Sales Channel (2018-2029) & (US$ Million)
Figure 37. Global Anti-Nuclear Radiation Drug Sales Market Share by Sales Channel in 2022 & 2029
Figure 38. North America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Sales Channel in 2022
Figure 39. North America Anti-Nuclear Radiation Drug Sales Market Share in Value by Sales Channel in 2022
Figure 40. Europe Anti-Nuclear Radiation Drug Sales Market Share in Volume by Sales Channel in 2022
Figure 41. Europe Anti-Nuclear Radiation Drug Sales Market Share in Value by Sales Channel in 2022
Figure 42. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Volume by Sales Channel in 2022
Figure 43. Asia-Pacific Anti-Nuclear Radiation Drug Sales Market Share in Value by Sales Channel in 2022
Figure 44. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Volume by Sales Channel in 2022
Figure 45. Latin America Anti-Nuclear Radiation Drug Sales Market Share in Value by Sales Channel in 2022
Figure 46. Middle East and Africa Anti-Nuclear Radiation Drug Sales Market Share in Value by Sales Channel in 2022
Figure 47. Key Raw Materials Price
Figure 48. Anti-Nuclear Radiation Drug Manufacturing Cost Structure
Figure 49. Anti-Nuclear Radiation Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed